rhodioloside has been researched along with Endotoxemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jingyan, L; Lingpeng, Z; Mingxing, M; Tianhua, Y; Yiming, Y; Yujuan, G | 1 |
| Chen, L; Feng, X; Liu, P; Ma, C | 1 |
| Chen, N; Deng, X; Feng, H; Guan, S; Guo, W; Huang, G; Huo, M; Lu, J; Song, B; Xiong, Y; Zhong, W | 1 |
3 other study(ies) available for rhodioloside and Endotoxemia
| Article | Year |
|---|---|
Salidroside Attenuates LPS-Induced Acute Lung Injury in Rats.
Topics: A549 Cells; Animals; Antioxidants; Caveolin 1; Endotoxemia; Glucosides; Humans; Lipopolysaccharides; Lung; Lung Injury; NF-kappa B; Phenols; Rats | 2017 |
Salidroside suppressing LPS-induced myocardial injury by inhibiting ROS-mediated PI3K/Akt/mTOR pathway in vitro and in vivo.
Topics: Animals; Cardiotonic Agents; Catalase; Cell Line; Dexamethasone; Endotoxemia; Gene Expression Regulation; Glucosides; Glutathione; Glutathione Peroxidase; Hemodynamics; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Nitric Oxide Synthase Type II; Phenols; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2017 |
Salidroside attenuates LPS-induced pro-inflammatory cytokine responses and improves survival in murine endotoxemia.
Topics: Animals; Anti-Inflammatory Agents; Cell Line; Cytokines; Down-Regulation; Endotoxemia; Glucosides; Inflammation; Lipopolysaccharides; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NF-kappa B; Phenols; Treatment Outcome | 2011 |